The pharmaceutical industry is sizable, with the US commanding the largest slice of the market. But competition within the sector is cutthroat and regulatory approval is an ongoing hurdle.
Pharmaceutical stocks are stocks from companies that research and produce pharmaceutical drugs and medical equipment.
The industry is dominated by big names like Pfizer, Johnson & Johnson and GlaxoSmithKline — famous for blockbuster drugs netting over USD$1 billion in annual sales, like Advair, Lipitor and Zoloft.
But there are numerous up-and-comers in the industry offering a spectrum of entry points for investors, like livestock medicine manufacturer Zoetis or Neoleukin Therapeutics, a biopharmaceutical company that targets immunological disorders.
The global pharmaceutical industry is massive — and the US holds the largest slice of the market. In 2018, worldwide pharmaceutical revenue sat at USD$1.2 trillion, with the US commanding a 40.4% share of the market with pharmaceutical sales of USD$484.5 billion.
Between 2011 and 2019, Canada’s pharmaceutical sales went up 35.3% to CAD$29.9 billion. Most of this is in retail drug sales, but hospitals also account for a chunk of the revenue.
According to Statista, the US also happens to have some of the highest prescription drug prices in the world — bad news for the general public but profitable for well-established drug companies like Pfizer and its shareholders. Given that drug prices in Canada and many other countries are much lower than drug prices in the US, millions of American residents import drugs from outside the country each year to save money.
Pharma stocks also have the potential to outperform the broader market. For example, the SPDR S&P Pharmaceuticals ETF has outperformed the S&P 500 since its 2006 inception.
And if the potential for profit isn’t incentive enough, investors also have the opportunity to back potentially groundbreaking, life-saving medicine — medicine that they or a loved one may one day rely on.
Pharmaceutical stocks present a potentially lucrative investment opportunity but carry significant risks, including competition from generic drugmakers, product patent expirations and the substantial cost of research and development (R&D).
It’s estimated that pharmaceutical companies spend approximately 20% of their revenue on research and development. In fact, in 2018, US companies collectively spent $80 billion on R&D, according to Statista. Between 2004 and 2019, anywhere from $790 million and $1.33 billion was spent each year on drug research in Canada.
What makes this expense especially unpalatable is the risk drug companies face in having their products rejected by regulatory authorities like the Health Products and Food Branch (HPFB) of Health Canada and the US Food and Drug Association (FDA). A company could spend millions researching and developing a product, only to have it rejected by the FDA.
Pharma companies also face steep competition from generic drugmakers attempting to undercut brand-name products with cheaper alternatives — especially for drugs with patent expirations on the horizon.
The industry is far from foolproof, and while pharma stocks could be a potentially profitable addition to your portfolio, make sure you understand the risks involved before you invest.
In the wake of the coronavirus pandemic, pharmaceutical companies have been thrust into the global spotlight as over 155 vaccine candidates scramble for regulatory clearance. Many of the big-name drug manufacturers with COVID-19 vaccines in trials have seen their stock prices rise alongside press releases of potential efficacy rates, including Pfizer, Moderna and AstraZeneca. These so-called COVID stocks may continue to see market growth, but the gains related to the pandemic may be short-lived.
There’s money to be made from selling a COVID-19 vaccine, but analysts warn that as more drug companies enter late-stage trials, the number of viable vaccine candidates will grow and no single manufacturer will be able to monopolize vaccine sales.
These pharmaceutical stocks hail from companies headquartered in the US and around the globe.
Pharmaceutical ETFs contain baskets of stocks from a range of businesses within the industry, including pharmaceutical companies, medical device manufacturers and more.
To invest, you’ll need a brokerage account. Explore your options below.
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.
Pharma stocks offer investors the opportunity to back groundbreaking drug research, but competition in this industry has the potential to threaten profits.
To invest in pharmaceutical companies, you’ll need a brokerage account. Compare your platform options to find the brokerage that fits your budget and investment goals needs.Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.
We break down which companies hold Ethereum, why they’re doing it and what ETH treasuries mean for markets and investors.
Want to invest in the Euro Stoxx 50 in Canada? Explore investment platforms and popular Euro Stoxx 50 index funds.
What are the best stocks for beginners with little money to invest?
Want to dive into investing but don’t have much to spend? Take a look at these types of stocks.
Meme stocks can produce large gains in short periods, but the stocks are volatile.
Your guide to how ETFs work and whether this type of investment is right for you.
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
We compare seven Wealthsimple alternatives to help you find the best investing platform or day-to-day bank account.
Want to invest in wheat companies? We’ve put together a list of wheat stocks you should keep your eye on.
Want to invest in REIT companies? We’ve put together a list of residential REIT stocks you should keep your eye on.
Want to invest in buy now, pay later companies? We’ve put together a list of BNPL stocks you should keep your eye on.
Want to invest in trucking companies? We’ve put together a list of trucking stocks you should keep your eye on.
Want to invest in space companies? We’ve put together a list of space stocks you should keep your eye on.
Want to invest in oil tanker companies? We’ve put together a list of oil tanker stocks you should keep your eye on.
Want to invest in diamond companies? We’ve put together a list of diamond stocks you should keep your eye on.
Want to invest in sports companies? We’ve put together a list of sports stocks you should keep your eye on.
These are the best renewable energy stocks to buy now in Canada.
